Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.44 AUD | +3.60% |
|
+3.60% | -28.00% |
Jun. 28 | Commonwealth Bank of Australia Trims Holding in Baby Bunting | MT |
Jun. 27 | Baby Bunting Secures Two Multi-Year Exclusivity Agreements; Shares Surge 20% | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company does not generate enough profits, which is an alarming weak point.
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 66.04 and 14.71 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Other Specialty Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-28.00% | 127M | B | ||
+22.22% | 28.33B | A- | ||
+10.22% | 6.13B | B- | ||
-17.07% | 4.13B | C | ||
+0.08% | 3.72B | C+ | ||
-2.61% | 1.67B | - | B- | |
-8.54% | 1.7B | C+ | ||
-6.84% | 1.36B | - | C | |
-16.72% | 1.14B | B- | ||
+0.52% | 641M | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BBN Stock
- Ratings Baby Bunting Group Limited